Pigmentary Disorders




(1)
Department of Dermatology, University of Pennsylvania, Penn Presbyterian Medical Center Medical Arts Building, Philadelphia, PA, USA

 




Abstract

Pigmentary disorders are characterized primarily by an increase or decrease in pigment. In this chapter, the type of pigment change is used to characterize these disorders.


Keywords
HyperpigmentationHypopigmentationVitiligo



12.1 Hyperpigmented Conditions



12.1.1 Localized Hyperpigmentation




(a)

Melanocytic neoplasms



  • See also Neoplastic: Melanocytic neoplasms

 

(b)

Dermal melanocytosis



  • See also Neoplastic: Melanocytic neoplasms

 

(c)

Lentigines



  • See also Neoplastic: Melanocytic neoplasms

 

(d)

Café-au-lait macules



  • See also Neoplastic: Melanocytic neoplasms

 

(e)

Longitudinal melanonychia



  • Ddx includes racial predisposition, trauma, drugs, pregnancy, Addison disease, Peutz-Jeghers syndrome, Laugier-Hunziker syndrome, SCC, onychomycosis, benign nail matrix nevi, and melanoma


  • Of more concern if involves a single nail, or demonstrates signs concerning for melanoma (e.g., Hutchinson’s sign with pigment extending onto the proximal nail fold)

 


12.1.2 Generalized Hyperpigmentation




(a)

Post-inflammatory hyperpigmentation (PIH)



  • Aka post-inflammatory pigment alteration (PIPA)


  • Melanin deposits in dermal melanophages secondary to inflammation

 

(b)

Erythema dyschromicum perstans (EDP)



  • “Ashy dermatosis” of blue-grey macules; may be post- inflammatory, some consider this a variant of lichen planus


  • Path: vacuolar change, perivascular or interface lymphs, and melanin incontinence


  • Increased incidence in Latin Americans


  • See also Papulosquamous: Lichenoid

 

(c)

Lichenoid dermatoses



  • These tend to leave more post-inflammatory pigment given the infiltrate along the dermal-epidermal junction


  • See also Papulosquamous: Lichenoid


I.

Lichen planus pigmentosus

 




  • A postinflammatory hyperpigmented form of LP that may be similar to EDP

 

(d)

Pigment deposition



  • See also Dermal: Depositional: Pigment deposition


I.

Ochronosis



  • Inherited/endogeneous form (alkaptonuria) and exogenous form (typically from hydroquinone)

 

II.

Hemochromatosis (iron deposition)



  • See also Nutritional Diseases

 

III.

Argyria (silver deposition)

 

IV.

Tattoo (pigment deposition)

 

V.

Drug-induced pigmentary deposition

A.

Minocycline



  • Blue pigment indicates iron on path




  • Type 1: blue-black at sites of acne, inflammation; Path = iron in dermis


  • Type 2: blue-grey on normal skin; anterior legs; Path = melanin and iron in dermis/subcutis


  • Type 3: diffuse muddy brown on sun-exposed areas; Path = increased basal layer melanin, dermal melanophages, no iron

 

B.

Amiodarone



  • Slate-gray photodistributed pigmentation

 

C.

Other medications



  • Clofazimine (lipofuscin), diltiazem, imipramine

 

 

 

(e)

Incontinentia pigmenti



  • See also Vesiculobullous: Intraepidermal blisters


  • Four stages: 1. Vesicular, 2. Verrucous, 3. Hyperpigmentation, 4. Hypopigmentation

 

(f)

Addison’s disease (adrenal insufficiency)



  • Hyperpigmenation, especially of sun-exposed areas, areas of trauma/scars, and creases/areolae/axillae/genitalia


  • Cultural note: famous case of President John F. Kennedy, who had hyperpigmented skin likely related to his Addison’s disease

 

(g)

Necrolytic acral erythema



  • Hyperpigmented plaques on dorsal feet/heels, from Hepatitis C

 

Oct 6, 2016 | Posted by in Dermatology | Comments Off on Pigmentary Disorders

Full access? Get Clinical Tree

Get Clinical Tree app for offline access